Kacena, Melissa A
- Indiana University Indianapolis · Internal Medicine (NIH department code)
From the FY2021 NIH awards this investigator leads as contact PI. The department is the award's.
FY2021 NIH rank #15,750
- R01 Holder
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2013 through FY2021Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2021 award categories
- Internal Medicine
NIH Funding · FY2021
Linked Award Amount
$671.4K
Full award amounts, FY2021
Award Records
2
Records listing this PI
Award-Linked Rank
#15,750
By linked amount among FY2021 PIs
Earliest Year Loaded
2013
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2021 award records by amount
NIH award records listing Kacena, Melissa A as a PI. Multi-PI records show the full award amount for context.
- 5R01DK108342-03R01Contact PICD166 Regulates Human and Murine Hematopoietic Stem Cell Function and the Hematopoietic NicheIndiana University Indianapolis · Internal Medicine (NIH department code)$354.4Kaward amount
- 5R01DK118782-03R01Contact PIOsteomacs and megakaryocytes interact to regulate hematopoietic stem cell functionIndiana University Indianapolis · Internal Medicine (NIH department code)$317Kaward amount
Award organization
Organizations that administered FY2021 awards listing Kacena, Melissa A as a PI.
FY2021 award administered by Indiana University Indianapolis (IN).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2013First NIH AwardIndiana University Indianapolis
- 2015$500K Cumulative Funding
- 2015R01 Grant Holder
- 2017$1M Cumulative Funding
- 2020$2M Cumulative Funding